Altshuler Shaham LTD Incyte Corp Transaction History

Altshuler Shaham LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$70.23 - $86.01 $21,981 - $26,921	-313 Reduced 43.35%	409 $29,000
Q4 2022 May 09, 2023	SELL	$67.18 - $84.11 $8,128 - $10,177	-121 Reduced 14.35%	722 $57,000
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $9,000 - $11,268	-136 Reduced 13.89%	843 $56,000
Q2 2022 Aug 10, 2022	SELL	$66.18 - $83.18 $16,346 - $20,545	-247 Reduced 20.15%	979 $74,000
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $80,940 - $97,724	1,226 New	1,226 $97,000
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $69,759 - $84,412	-864 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$85.07 - $109.69 $344,788 - $444,573	-4,053 Reduced 82.43%	864 $78,000
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $364,446 - $535,173	4,913 Added 122825.0%	4,917 $511,000
Q1 2020 May 12, 2020	SELL	$63.18 - $85.97 $9,287 - $12,637	-147 Reduced 97.35%	4 $0
Q4 2019 Feb 11, 2020	BUY	$73.04 - $95.72 $1,972 - $2,584	27 Added 21.77%	151 $13,000
Q3 2019 Nov 12, 2019	SELL	$72.82 - $86.52 $72 - $86	-1 Reduced 0.8%	124 $9,000
Q2 2019 Aug 06, 2019	SELL	$73.52 - $88.7 $7,425 - $8,958	-101 Reduced 44.69%	125 $11,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $14,364 - $19,926	226 New	226 $19,000

652

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.